TipRanks
Go Ultimate75% OFF

Femasys (FEMY) Stock Price & Analysis

599 Followers

FEMY Stock Chart & Stats

$1.37$0.06(4.58%)
At close: 4:00 PM EST
$2$3Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$1.30 - $1.41
52-Week Range
$1.26 - $22.22
Previous Close
$1.31
Volume
N/A
Average Volume (3M)
112.58K
Market Cap
$11.47M
Enterprise Value
$17.38M
Total Cash (Recent Filing)
$1.44M
Total Debt (Recent Filing)
$4.79M
Price to Earnings (P/E)
―
Beta
0.57
Next Earnings
Nov 17, 2026 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Capital Infusion

The $30 million financing strengthens near-term liquidity relative to the company’s substantial cash burn and provides resources to continue developing and commercializing its women’s-health technologies. It may reduce immediate funding pressure over the next several quarters, although warrants can increase dilution.

Gross Margin

A roughly 50% gross margin indicates that the company’s products retain meaningful economic value after direct costs, providing a foundation for improved operating leverage if revenue scales. This underlying margin profile is constructive, although current losses remain far too large for the revenue base.

Board Governance

The appointment adds an independent director with Audit and Compensation Committee responsibilities, supporting formal oversight as the company deploys new capital and develops its commercial strategy. A defined term through 2029 also provides continuity in board-level governance during execution.

Bears Say

Severe Unprofitability

The company is generating losses several times larger than its revenue, showing that its current operating structure has not reached viable scale. Until revenue expands materially or expenses fall, this level of unprofitability will continue to consume capital and constrain strategic flexibility.

Persistent Cash Burn

Heavy operating and free-cash-flow deficits indicate that the business cannot currently fund its activities from internally generated cash. Continued burn increases reliance on external financing, and the absolute outflow remains substantial relative to the company’s approximately $2.3 million revenue base.

Balance-sheet Deterioration

Higher leverage combined with sharply reduced equity weakens financial flexibility and increases dependence on financing to support operations. The deterioration also reflects cumulative losses, leaving a smaller capital buffer to absorb execution setbacks or fund expansion without further shareholder impact.

Femasys News

FEMY FAQ

What was Femasys’s price range in the past 12 months?
Femasys lowest stock price was $1.26 and its highest was $22.22 in the past 12 months.
What is Femasys’s market cap?
Femasys’s market cap is $11.47M.
When is Femasys’s upcoming earnings report date?
Femasys’s next earnings report is estimated for Nov 17, 2026 (not yet confirmed), which is in 7 days.
How were Femasys’s earnings last quarter?
Femasys released its earnings results on Aug 14, 2026. The company reported -$1.33 earnings per share for the quarter, missing the consensus estimate of -$1.31 by -$0.02.
Is Femasys overvalued?
According to Wall Street analysts Femasys’s price is currently Undervalued.
Does Femasys pay dividends?
Femasys does not currently pay dividends.
What is Femasys’s EPS estimate?
Femasys’s EPS estimate is -0.60.
How many shares outstanding does Femasys have?
Femasys has 8,375,027 shares outstanding.
What happened to Femasys’s price movement after its last earnings report?
Femasys reported an EPS of -$1.33 in its last earnings report, missing expectations of -$1.31. Following the earnings report the stock price went down -5.677%.
Which hedge fund is a major shareholder of Femasys?
Hedge funds hold Femasys shares: the largest hedge-fund position in Femasys is 71,887,568 shares, and hedge funds decreased their holdings by 7.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology